Largest biotech companies in the United States by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 10 biotech companies in the United States ranked by total debt, at SAR 204.8B, ahead of Gilead Sciences (SAR 93.5B) and Biogen (SAR 23.6B). Figures as of 20 Nov 2026, 17:06 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
10
First
AmgenSAR 204.8B
Median
SAR 2.1B
Combined market value
SAR 2.76T
Countries
1
Not ranked
10no total debt on file

Market values as of .

United States
All sectors
Biotech
SAR
Clear filters
Largest biotech companies in the United States by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareSAR 204.8BSAR 892.1BSAR 1,649.20 0.76% up 30% up United States
2Gilead SciencesGILD · Health CareSAR 93.5BSAR 785.5BSAR 633.31 1.37% up 31% up United States
3BiogenBIIB · Health CareSAR 23.6BSAR 138.4BSAR 936.07 0.97% up 41% up United States
4Halozyme TherapeuticsHALO · Health CareSAR 8BSAR 39.7BSAR 348.25 0.23% down 32% up United States
5ModernaMRNA · Health CareSAR 2.2BSAR 299.4BSAR 740.06 1.03% down 740% up United States
6RepligenRGEN · Health CareSAR 2BSAR 39.7BSAR 621.17 2.77% down 5% up United States
7Bio-TechneTECH · Health CareSAR 750.3MSAR 42.9BSAR 272.83 0.03% up 18% up United States
8Adaptive BiotechnologiesADPT · Health CareSAR 492.2MSAR 16.8BSAR 103.77 1.39% down 51% up United States
9Scholar Rock HoldingSRRK · Health CareSAR 374.1MSAR 23.1BSAR 189.30 0.18% up 25% up United States
10CG OncologyCGON · Health CareSAR 11.3MSAR 27.2BSAR 304.04 1.04% down 93% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7515 SAR). 10 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies in the United States rank first by total debt?

Amgen (SAR 204.8B), Gilead Sciences (SAR 93.5B) and Biogen (SAR 23.6B) are the top three of the 10 biotech companies in the United States ranked by total debt as of 20 Nov 2026, 17:06 UTC.

How many biotech companies in the United States are in this ranking?

10 are ranked by total debt. 10 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 10 biotech companies in the United States ranked by total debt have a combined market value of SAR 2.76T as of 20 Nov 2026, 17:06 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.